X
19
Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.
One of their notable products is FULVESTRANT, with a corresponding application number 210326.
Regulatory Information RX
With a dosage strength 250MG/5ML (50MG/ML)
Dosage Form Route SOLUTION; INTRAMUSCULAR
Reference Listed Drug No
Approved since 2019-05-20